Connection

Quique Bassat to Methylprednisolone

Back to Details
This is a "connection" page, showing publications Quique Bassat has written about Methylprednisolone.
Quique Bassat
Connection Strength
0.025
Methylprednisolone
  1. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clin Infect Dis. 2021 05 04; 72(9):e373-e381.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.